Summary of Key Points Core Viewpoint - Shanghai Aohua Endoscopy Co., Ltd. has announced a share repurchase plan aimed at utilizing the repurchased shares for employee stock ownership plans or equity incentives, with a total repurchase amount expected to be between RMB 100 million and RMB 200 million [1][3]. Repurchase Plan Details - The repurchase plan was first disclosed on January 6, 2025, with an implementation period from January 3, 2025, to January 2, 2026 [1]. - The maximum repurchase price is set at RMB 45.00 per share [1]. - The total number of shares repurchased is 2,499,471, accounting for 1.86% of the total share capital [3]. Implementation Status - As of the announcement date, the company has completed the share repurchase as per the disclosed plan, with a total expenditure of RMB 100,004,825.58 [3]. - The repurchase was conducted through the Shanghai Stock Exchange trading system using self-owned funds and a special loan from CITIC Bank [3]. Shareholder Transactions - During the repurchase period, there were no transactions involving the company's directors, supervisors, senior management, or controlling shareholders, except for specific increases in shareholdings by certain executives [4][5]. Share Capital Changes - Before the repurchase, the total share capital was 134,587,250 shares, which increased to 134,665,250 shares post-repurchase [6]. - The repurchased shares will be used for employee stock ownership plans or equity incentives, and any unutilized shares within three years will be canceled [6].
澳华内镜: 关于股份回购实施结果暨股份变动的公告